Shield to acquire Echodyne in a transaction valued at $5.3 billion and raise $2.5 billion at a $28.8 billion valuation

M&A — Shield to acquire Echodyne in a transaction valued at $5.3 billion and raise $2.5 billion at a $28.8 billion valuation  Shield AI

Read the original at M&A ↗

Auto-published by the finit.news Events monitor from M&A; summarized by AI and may contain errors — verify against the primary source. November 5, 2026.